[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content

The schizophrenia and Toxoplasma gondii connection: Infectious, immune or both?

  • Original Research
  • Published:
Advances in Therapy Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Introduction

Recent research has suggested a possible link between toxoplasmic agents and schizophrenia. We aimed to assess this by measuring Toxoplasma gondii-associated antibodies in schizophrenia patients and controls

Methods

We used a commercially available enzyme-linked immunosorbent assay (ELISA) kit to measure the level of immunoglobulin G (IgG) and IgM antibodies in serum samples from schizophrenia patients (n=40) and from a group of non-schizophrenic control subjects (n=37)

Results

Among schizophrenic patients, 16 (40%) showed IgG seropositivity and two (5%) showed IgM seropositivity. Among the control group, five (13.5%) were found have IgG seropositivity and one (2.7%) showed IgM seropositivity. In our study we found that IgG T gondii antibodies were significantly higher in schizophrenia patients compared with controls

Conclusions

This study supports the theory that toxoplasmic agents may have a role in the aetiology of schizophrenia

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001;58:1032–1037.

    Article  PubMed  CAS  Google Scholar 

  2. Leweke FM, Gerth CW, Koethe D, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:4–8.

    Article  PubMed  Google Scholar 

  3. Susser E, Hoaek HW, Brown A. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am J Epidemiol. 1998;147:213–216.

    PubMed  CAS  Google Scholar 

  4. Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, Sørensen TL, Hougaard D, Yolken RH. Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull. 2007;33:741–744.

    Article  PubMed  Google Scholar 

  5. Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol. 2003;63:253–268.

    Article  PubMed  Google Scholar 

  6. Amminger GP, McGorry PD, Berger GE, et al. Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry. 2007;61:1215–1217.

    Article  PubMed  CAS  Google Scholar 

  7. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry. 2005;162:767–773.

    Article  PubMed  Google Scholar 

  8. Jackson MH, Hutchinson WM. The prevelance and source of Toxoplasma infection in the environment. Adv Parasitol. 1989;28:55–105.

    Article  PubMed  CAS  Google Scholar 

  9. Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology. 2005;38:87–90.

    Article  PubMed  CAS  Google Scholar 

  10. Skallova A, Kodym P, Frynta D, Flegr J. The role of dopamine in Toxoplasma-induced behavioral alterations in mice: an ethological and ethopharmacological study. Parasitology. 2006;2:1–11.

    Google Scholar 

  11. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis 1 Disorders (SCID-1), Clinical Version. Washington DC: American Psychiatric Publishing, Inc; 1977.

    Google Scholar 

  12. Niebuhr DW, Millikan AM, Cowan DN, Yolken R, Li Y, Weber NS. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry. 2008;165:99–106

    Article  PubMed  Google Scholar 

  13. Li Q, Luo XL. Controlled study of schizophrenia and affective disorders and Toxoplasma infection. Acta Acad Med Hubei. 1999;20:223–225.

    Google Scholar 

  14. Yolken RH, Bachmann S, Rouslanova I, et al. Antibodies Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis. 2001;32:842–844.

    Article  PubMed  CAS  Google Scholar 

  15. Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr Bull. 1995;21:167–171.

    PubMed  CAS  Google Scholar 

  16. Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case control study of selected risk factors. Schizophr Res. 2000;46:17–23.

    Article  Google Scholar 

  17. Holliman RE. Toxoplasmosis, behavior and personality. J Infect. 1997;35:105–110.

    Article  PubMed  CAS  Google Scholar 

  18. Ledgerwood LG, Ewald PW, Cochran GM. Genes, germs and schizophrenia an evolutionary perspective. Perspect Biol Med. 2003;46:317–348.

    Article  PubMed  CAS  Google Scholar 

  19. Flegr J, Hrdy I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol (Praha). 1994;41:122–126.

    CAS  Google Scholar 

  20. Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 2003;62:237–244.

    Article  PubMed  Google Scholar 

  21. Conejero-Goldberg C, Torrey EF, Yolken RH. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res. 2003;60:65–69.

    Article  PubMed  Google Scholar 

  22. Selten JP, Kahn RS. Schizophrenia after prenatal exposure to Toxoplasma gondii? Clin Infect Dis. 2002;35:633–634.

    Article  PubMed  Google Scholar 

  23. Torrey EF, Yolken RH. Schizophrenia and toxoplasmosis. Schizophr Bull. 2007;33:727–728.

    Article  PubMed  Google Scholar 

  24. Zhu S, Guo MF, Feng QC, Fan JM, Zhang LX. Epidemiological evidences from China assume that psychiatric-related diseases may be associated with Toxoplasma gondii infection. Neuro Endocrinol Lett. 2007;28:115–120.

    Article  PubMed  CAS  Google Scholar 

  25. Cetinkaya Z, Yazar S, Gecici O, Namli MN. Anti-Toxoplasma gondii antibodies in patients with schizophrenia — preliminary findings in a Turkish sample. Schizophr Bull. 2007;33:789–791.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gulden Sonmez Tamer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamer, G.S., Dundar, D., Yalug, I. et al. The schizophrenia and Toxoplasma gondii connection: Infectious, immune or both?. Adv Therapy 25, 703–709 (2008). https://doi.org/10.1007/s12325-008-0063-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-008-0063-5

Keywords